Zdrowie i gospodarka · 09/04/2007

FDA Withdraws Approval for Tigan Suppositories Due to Lack of Efficacy

The FDA has withdrawn approval for Tigan suppositories, a new drug application for trimethobenzamide hydrochloride, citing insufficient evidence of effectiveness, and declared the marketing of unapproved versions as unlawful